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ABSTRACT Saccharomyces cerevisiae Srs2, in addition to its well-documented antirecombination activity, has been proposed to play a
role in promoting synthesis-dependent strand annealing (SDSA). Here we report the identification and characterization of an SRS2
mutant with a single amino acid substitution (srs2-F891A) that specifically affects the Srs2 pro-SDSA function. This residue is located
within the Srs2–Rad51 interaction domain and embedded within a protein sequence resembling a BRC repeat motif. The srs2-F891A
mutation leads to a complete loss of interaction with Rad51 as measured through yeast two-hybrid analysis and a partial loss of
interaction as determined through protein pull-down assays with purified Srs2, Srs2-F891A, and Rad51 proteins. Even though previous
work has shown that internal deletions of the Srs2–Rad51 interaction domain block Srs2 antirecombination activity in vitro, the Srs2-
F891A mutant protein, despite its weakened interaction with Rad51, exhibits no measurable defect in antirecombination activity
in vitro or in vivo. Surprisingly, srs2-F891A shows a robust shift from noncrossover to crossover repair products in a plasmid-based gap
repair assay, but not in an ectopic physical recombination assay. Our findings suggest that the Srs2 C-terminal Rad51 interaction
domain is more complex than previously thought, containing multiple interaction sites with unique effects on Srs2 activity.
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CELLS possess multiple pathways to respond to the variedtypes ofDNAdamage that are caused byboth endogenous
and exogenous sources. Homologous recombination (HR) is a
DNA damage repair/tolerance pathway with the potential to
target a variety of DNA lesions, including single-stranded
DNA (ssDNA) gaps and double-stranded DNA breaks (DSBs)
(Kowalczykowski et al. 2016). HR requires the presence of
intact homologous DNA donor sequences that serve as tem-
plates for the repair or bypass of DNA lesions. For DSBs to be
channeled to HR, the broken ends must initially be resected
to generate long stretches of 39 overhang ssDNA (Symington
and Gautier 2011). The resulting ssDNA is subsequently
coated with Rad51 protomers forming a nucleoprotein fila-
ment that carries out two key HR reactions: homology search
and DNA strand invasion (Sung 1994). The invading ssDNA
39 end primes DNA synthesis using the invaded duplex DNA
as a repair template (McVey et al. 2016). The resulting ex-
tended displacement loop structure (D-loop) may then be
channeled to one of two main subpathways: synthesis-
dependent strand annealing (SDSA) or the double Holliday
junction (dHJ) pathway (Jenkins et al. 2016). While SDSA
produces exclusively noncrossover (NCO) repair products,
the dHJ pathway has the potential to produce either cross-
over (CO) or NCO products depending on how the dHJ in-
termediate is processed.
Misregulation of HR can lead to genomic rearrangements
and overall genomic instability despite its important role in
DNA repair. To maintain genome stability, the HR pathway is
tightly controlled and regulated at multiple steps. Since
Rad51 filament formation is a crucial step in initiating the
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key HR functions of homology search and strand invasion,
there has been a strong focus on HR regulation at the early
stages of Rad51 filament assembly and disassembly. To reg-
ulate Rad51 filaments, cells possess protein factors that help
stabilize Rad51 filaments as well as factors that help desta-
bilize them (Heyer et al. 2010).
Srs2 helicase is amember of the Superfamily 1 UvrD group
of DNA helicases conserved from bacteria to mammals (Rong
and Klein 1993; Niu and Klein 2017). Srs2 is a paradigmatic
antirecombinase that acts by disrupting Rad51 filaments
(Krejci et al. 2003; Veaute et al. 2003). This antirecombina-
tion activity of Srs2 is well supported by genetic evidence
(Rong et al. 1991; Aboussekhra et al. 1992; Chanet et al.
1996; Fabre et al. 2002), as well as biochemical evidence that
shows Srs2 can efficiently disrupt Rad51 filaments in vitro
(Krejci et al. 2003; Veaute et al. 2003). Single-molecule ex-
periments directly visualized the processive dissociation of
Rad51 from ssDNA at a rate of 50 Rad51 protomers per
second (Kaniecki et al. 2017). Efficient Srs2-mediated disrup-
tion of Rad51–ssDNA filament requires Rad51 ATPase activ-
ity, suggesting that Srs2 directly regulates the Rad51 ATPase
(Antony et al. 2009; Kaniecki et al. 2017). Several biochem-
ical and biophysical studies have shown that blocking the
physical interaction between Srs2 and Rad51 prevents Srs2
from efficiently disrupting Rad51 filaments in vitro including
using the srs2-D(875–902) mutant protein (Antony et al.
2009; Colavito et al. 2009; Seong et al. 2009; Kaniecki
et al. 2017). However, genetic and cytological studies
of Rad51 interaction-deficient srs2 mutants such as
srs2-D(875–902) have found no evidence to support the im-
portance of Srs2–Rad51 physical interaction in antirecombi-
nation in vivo (Colavito et al. 2009; Burkovics et al. 2013;
Sasanuma et al. 2013). Despite exhibiting significant defects
in Rad51 filament disruption in vitro, srs2-D(875–902)
does not suppress rad18D DNA damage sensitivity
(Colavito et al. 2009), a genetic interaction that is used as
an indirect indicator of defects in Srs2 antirecombination
activity. Furthermore, meiotic overexpression of wild type
(WT) and srs2-D(875–902), unlike helicase-deficient srs2-
K41A, efficiently removes Rad51 foci from chromosomes,
further indicating that the Srs2–Rad51 interaction mediated
by Srs2 residues 875–902 may be dispensable for Srs2 anti-
recombination function in vivo (Sasanuma et al. 2013). This
apparent discrepancy between the in vitro and in vivo studies
may be because of a protein factor/modificationmissing from
the in vitro biochemical reactions that is present in vivowhich
may have a greater impact on Srs2 Rad51-filament disruption
activity than on the Srs2–Rad51 interaction. One such factor
could be Rad52, which is not only required for the nucleation
of Rad51 filaments on ssDNA but also to protect Rad51–
ssDNA filament against dissociation by Srs2 (Ma et al. 2018).
Srs2 has also been shown to promote formation of NCO
repair products (Ira et al. 2003; Robert et al. 2006; Welz-
Voegele and Jinks-Robertson 2008; Mitchel et al. 2013;
Miura et al. 2013), at least in part, by unwinding extended
D-loops to promote the SDSA subpathway in HR (Liu et al.
2017; Piazza et al. 2019). One proposed mechanism suggests
that Srs2 and other enzymes such as human RECQL5 may
promote SDSA through its Rad51 filament disruption activity
by removing Rad51 from the second end of the break, thus
facilitating the annealing of the newly synthesized strand to
the second resected end (Ira et al. 2003; Mitchel et al. 2013;
Paliwal et al. 2014). This hypothesis would predict that any
mutation that affects the Srs2 antirecombination function
would also affect the Srs2 pro-SDSA function. Alternatively,
Srs2 pro-SDSA function may rely on another unique bio-
chemical activity separate from its well-characterized
Rad51 filament disruption activity. One such activity could
be its ability to unwind extended D-loops, which would pro-
mote the SDSA pathway and the formation of NCO repair
products (Ira et al. 2003; Dupaigne et al. 2008; Liu et al.
2017; Piazza et al. 2019).
Here, we identify a putative BRC repeat motif (residues
891–894) within the previously mapped Srs2–Rad51 inter-
action domain (residues 862–914). We find that mutating
F891 within this motif weakens the Srs2–Rad51 physical in-
teraction. Interestingly, srs2-F891A promotes a robust shift
fromNCO to CO repair products in a gap repair assay without
any measurable effect on overall repair efficiency. This shift
toward CO repair products suggests the srs2-F891Amutation
may be interfering with the Srs2 pro-SDSA function (Aylon
et al. 2003; Ira et al. 2003; Mitchel et al. 2013). However,
srs2-F891A does not exhibit a shift toward CO repair in an
ectopic physical recombination system. Therefore, the srs2-
F891A mutation interferes with the Srs2 pro-SDSA function
only under specific circumstances. Furthermore, despite its
weakened interactionwith Rad51, srs2-F891A does not affect
Srs2 antirecombination function as examined both in vivo
and in vitro. Our findings suggest that the srs2-F891A muta-
tion, under certain circumstances, selectively disrupts the
Srs2 pro-SDSA function without affecting its antirecombina-
tion activity, which in turn argues in favor of the idea that the
Srs2 pro-SDSA function may be dictated by a biochemical
activity separate and unique from its Rad51 filament disrup-
tion activity. These findings further highlight the complexity
of the Srs2 C-terminal Rad51 interaction domain, suggesting




Full-length, WT budding yeast Srs2 coding DNA was cloned
into the yeast 2-hybrid prey vector (pJG4-5) in framewith the
B42 activation domain and an HA tag using EcoRI and XhoI
restriction sites. The srs2-F891A mutant allele was con-
structed via site-directed mutagenesis using pJG4-5-Srs2 as
a template. Full-length budding yeast RAD51was cloned into
2-hybrid bait vector (pEG202) in frame with the LexA do-
main using EcoRI and XhoI restriction sites. To prevent trans-
lation past the B42 and LexA domains in pJG4-5 and pEG202
negative control vectors, in-frame stop codons were
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introduced at the EcoRI sites. The list of plasmids used is
found in Supplemental Material, Table S1 in File S1.
BuddingyeastEGY48strain (seeTableS2 inFileS1 fora list
of all Saccharomyces cerevisiae strains used) was transformed
with pSH18-34 LacZ reporter plasmid, as well as prey and
bait vectors as indicated in Figure 1C. The resulting strains
were grown on selective media and b-galactosidase activity
measured in Miller units as previously described (Harshman
et al. 1988).
DNA damage sensitivity
For the quantitative UV survival assay, yeast strains (Table S2
in File S1) were grown overnight rotating at 30 and then
diluted appropriately and plated onto YPD, followed by UV
irradiation at the indicated doses (Spectrolinker, XL-1500 UV
cross-linker). The plates were incubated at 30 for 2 days.
The number of colonies in UV-treated cells was compared to
that of untreated controls. For quantitative the gamma-
irradiation sensitivity assay, log phase cultures of strains
were diluted and plated onto YPD followed by gamma radi-
ation from a cesium-137 source at the indicated doses. The
plates were then incubated for 2 days at 25. Room temper-
ature (25) incubation was selected because rad55D
strains are known to be cold-sensitive (Lovett and Mortimer
1987). The number of colonies in gamma-irradiated strains
was compared to untreated controls.
For the serial dilution assays, the OD600 of overnight yeast
cultures was adjusted to 2.0, followed by six fivefold serial
dilutions. 2 ml of each dilution was spotted in order onto YPD
plates with or without DNA damage induction.
DSB repair efficiency, crossover frequency, and
recombination rate analyses
Gap repair, ectopic physical recombination, and spontaneous
inverted repeat assays were carried out as previously de-
scribed (Ira et al. 2003; Spell and Jinks-Robertson 2004a;
Mitchel et al. 2013). To generate the radioactive probe for
the ectopic physical recombination assay, the following two
primers were used: 59-TGGATGATATTTGTAGTATGGCGG-39
and 59-CCGCATGGGCAGTTTACCT-39.
Protein purification, affinity pull-down assay,
immunoblots
S. cerevisiae His9-tagged wild type and srs2-F891A were
purified to near homogeneity from Escherichia coli (Figure
S1 in File S1), and native Rad51 was purified from the
cognate host as described (Liu et al. 2017). Pull-downs
were conducted as previously described with 1.34 mM
Rad51 and 0.424 mM His9-tagged Srs2 at the indicated
concentrations of KCl (Colavito et al. 2009). The resulting
eluates were analyzed on 4–20% Mini-PROTEAN TGX
Stain-Free Protein Gels (Biorad, Hercules, CA). Srs2 bands
were visualized by activating the stain-free gel by exposure
to 1 min of UV transillumination with the ChemiDoc Touch
(Biorad). Rad51 bands were visualized using immunoblot
analysis with rabbit anti-Rad51 serum (a generous gift
from Dr. Akira Shinohara). The band intensities were ana-
lyzed using ImageJ software.
To examine the interaction between Srs2 and Rad55,
200 nM purified GST–Rad55–His6–Rad57 or 200 nM GST
(GE Healthcare) were incubated with 50 nM purified His9-
tagged Srs2 (WT or F891A) in buffer K (20 mM potassium
phosphate pH 7.4, 10% glycerol, 0.5mMEDTA, 0.01%NP-40
alternative, 1 mM DTT) with 150 mM NaCl for 1 hr at room
temperature. Eighty microliters of preequilibrated and BSA-
blocked Glutathione Sepharose 4B bead slurry was added
to the protein mixtures and incubated while mixing for an
additional 1.5 hr at room temperature. The beads were
centrifuged and washed twice with 150 ml of K buffer. The
pulled-down protein complexes were eluted off the beads by
boiling the beads in 25 ml of 23 Laemmli sample buffer
(26.3% glycerol, 65.8 mM Tris-Cl pH 6.8, 2.1% SDS, 0.01%
bromophenol blue, 710 mM b-mercaptoethanol) for 5 min.
The resulting eluate was loaded on 4–20% Mini-PROTEAN
TGX Precast Protein Gels (Biorad). The protein bands were
visualized through immunoblot analysis using anti-Srs2
(sc11991; Santa Cruz Biotechnology) and anti-Rad55
(Bashkirov et al. 2000) antibodies.
Whole protein was extracted from wild-type, srs2-F891A,
and srs2D strains using the trichloroacetic acid (TCA) extrac-
tion protocol described in Clontech Yeast Protocols Hand-
book (Protocol No. PT3024-1, Version No. PR973283).
For protein detection by immunoblotting, TCA whole cell
extracts were separated by SDS-PAGE and analyzed by im-
munoblotting using anti-PGK1 (ab197960; Abcam) and anti-
Srs2 (sc11991; Santa Cruz Biotechnology) antibodies.
ATPase assay
A coupled spectrophotometric ATPase assay was performed as
describedpreviouslywithminormodifications (Liu et al. 2006).
Reactions were carried out in 35 mM Tris-acetate pH 7.5,
100 mM NaCl, 7 mM magnesium acetate, 2 mM ATP, 1 mM
DTT, 0.25mg/ml BSA, and an ATP regenerating system [30 U/
ml pyruvate kinase (Sigma, St. Louis,MO), 3mMphosphoenol-
pyruvate (Sigma), and 0.3mg/ml NADH (Sigma)], in the pres-
ence or absence of 10 mM (in nucleotides) fX174 ssDNA
cofactor. Purified Srs2 WT or F891A (5 nM) was added to
initiate the reactions at 30. ATP hydrolysis rates were esti-
mated from the measured changes in absorbance at 340 nm
within the linear portions of time courses.
D-loop disruption assay
The D-loop disruption assay was carried out as recently de-
scribed (Liu et al. 2017).
Assay for Rad51 filament disruption
A 59-biotinylated 100-mer with sequence 59-ATGTCTAA
TATTCAAACTGGCGCCGAGCGTATGCCGCATGACCTTTCC
CATCTTGGCTTCCTTGCTGGTCAGATTGGTCGTCTTATTAC
CATTTCAACTA-39 was immobilized onto magnetic strepta-
vidin beads (M-280; Thermo Fisher) as described by Liu
et al. (2011). Two ml of suspended beads were incubated
Srs2 in Crossover Control 1135
with 1 mM nucleotides ssDNA and agitated with 300 nM
Rad51 in 10 ml reaction buffer (35 mM Tris-acetate,
7 mM magnesium acetate, 4 mM ATP, 50 mg/ml BSA, and
1 mM DTT) for 20 min. Beads were washed with reaction
buffer to remove free Rad51. Beads were then agitated with
10 ml of reaction buffer with or without 25 nM Srs2 or Srs2-
F891A for 20min. Nucleotides (100mM) of noncomplemen-
tary scavenger DNA with the sequence 59-CTTGCTGAATA
TATCTGGAAGTATTATGCAGATTCATTATTCGAAGGGGGAGG
CGGGGGTGGAAAGCCTATCCCTAACCCTCTCCTCGGTCTC
GATTCTA-39 were added and further incubated for 10 min.
Supernatant containing unbound proteins was collected and
tested for the amount of Rad51 by immunoblot analysis with
mouse anti-Rad51 (sc-133089; Santa Cruz Biotechnology) an-
tibody using a 1:500 dilution. All steps were carried out at 30.
Data availability
Strains and plasmids are available upon request. Table S1 lists
the two-hybrid plasmids used. Table S2 lists the S. cerevisiae
strains used. Figure S1 shows the purified Srs2-F891A pro-
tein. Figure S2 shows the Srs2-Rad55 interaction data. Figure
S3 shows ATPase data. Figure S4 shows DNA damage sensi-
tivity data. Figure S5 shows tetrad data for absence of syn-
thetic lethalities. Supplemental material available at
FigShare: https://doi.org/10.25386/genetics.8179493.
Results
The Rad51 interaction domain of Srs2 contains a BRC
repeat motif
HumanRECQL5, apotential functionalhomologof yeast Srs2,
was previously proposed to possess a BRC repeat motif me-
diating its interactions with Rad51 much like the interaction
between BRCA2 and Rad51 (Islam et al. 2012). In fact, the
authors also reported finding BRC repeat-like motifs in other
known yeast HR proteins such as Srs2, Mph1, Sgs1, and Pif1
(Islam et al. 2012). The Srs2 BRC repeat motif previously
proposed by Islam et al. (2012) spans amino acids 837
through 840 (FTAA). However, srs2-F837A mutant protein
exhibited no Rad51 interaction defect, even though, at low
concentrations, it exhibited a slight decrease in inhibiting
D-loop formation in vitro (Islam et al. 2012). This prompted
us to look further within the Srs2 sequence for other potential
BRC repeat motifs. We particularly focused our search on
amino acids 875 through 902, a region whose deletion
(srs2-D(875–902)) has been shown to effectively disrupt
Srs2–Rad51 physical interaction in vitro (Colavito et al.
2009). We identified residues 891–894, FHSP, as a potential
BRC repeat motif (Figure 1A). Even though BRC repeat mo-
tifs typically have an alanine at the fourth site, there is pre-
cedence for a proline at this position in theGallus gallus BRC5
repeat motif (Warren et al. 2002) (Figure 1B).
srs2-F891A exhibits reduced interaction with Rad51
Crystallographic data have shown that the phenylalanine in a
BRC repeat functions as ahydrophobic key that iswedged into
a hydrophobic Rad51 pocket (Pellegrini et al. 2002). We,
therefore, mutated F891 to alanine to eliminate this potential
hydrophobic interaction without significantly altering the
overall charge and polarity. We used yeast 2-hybrid assays
to examine how the predicted BRC repeat region affects the
Srs2–Rad51 interaction. The analysis shows that mutating
F891 to alanine greatly reduces the interaction between
Srs2 and Rad51 (Figure 1C). To further examine the Rad51
interaction defect conferred by the srs2-F891A mutation, we
purified His9-tagged WT Srs2 and Srs2-F891A from E. coli to
near homogeneity (Figure S1 in File S1) and tested the phys-
ical interaction with Rad51 (Figure 1D). We found that com-
pared to WT Srs2, srs2-F891A showed a consistent decrease
in Rad51 interaction in vitro over a range of salt concentra-
tions (Figure 1D).
To verify that the srs2-F891A mutation does not cause
overall misfolding that blocks all protein interactions, we
tested its interaction with another known Srs2 interacting
protein, Rad55 (Liu et al. 2011). We found that Srs2-F891A
is just as adept as WT Srs2 in interacting with Rad55 (Fig-
ure S2 in File S1) at a salt concentration (150 mM) that
caused a significant reduction in Rad51 interaction with
Srs2-F891A (Figure 1D). The intact Srs2-F891A-Rad55 in-
teraction indicates that this mutant Srs2 is not grossly
misfolded.
To further assess whether Srs2-F891A mutation affects
protein folding and stability, we compared its endogenous
protein expression levels to that of wild-type Srs2. Generally,
misfolded proteins are associated with a reduction in protein
stability that translates into lower steady-state protein levels.
We foundWTSrs2 and Srs2-F891A are expressed to the same
steady-state level, further indicating Srs2-F891Amutant pro-
tein is properly folded (Figure 2D).
In accordance with these findings, purified mutant Srs2-
F891A protein exhibits levels of ATPase activity comparable
to that of WT Srs2 (Figure S3 in File S1).
srs2-F891A mutant is proficient at antirecombination
in vivo
The observation that Srs2-F891A is defective in Rad51 inter-
action would suggest that it is also defective in Rad51 fila-
ment disruption, and consequently, antirecombination. To
investigate the antirecombination effects of the srs2-F891A
mutation in vivo, we examined sensitivity of the mutant to
various DNA-damaging agents. The srs2-F891A mutant dis-
played no statistically significant or reproducible sensitivity
to ultraviolet light (UV), ionizing radiation (IR), or methyl
methanesulfonate (MMS) beyond that observed in WT
strains (Figure 2, A–C and Figure S4 in File S1). Moreover,
we investigated its genetic interactions with rad55D and
rad18D, whose DNA damage sensitivity is suppressed by
srs2D (Lawrence and Christensen 1979; Rong et al. 1991;
Liu et al. 2011). The observed suppression in the double de-
letion mutants, srs2D rad55D and srs2D rad18D, are attrib-
uted to loss of Srs2 antirecombination activity. While the
srs2Dmutation partially suppressed the rad55D IR sensitivity
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as expected (Liu et al. 2011), we observed no suppression of
rad55D IR sensitivity in srs2-F891Amutant background (Fig-
ure 2B), further suggesting that srs2-F891A is proficient at
antirecombination in vivo.
Early studies showed that srs2 suppresses the DNA dam-
age sensitivities of rad6 and rad18 mutants (Lawrence and
Christensen 1979; Rong et al. 1991), which represents the
key phenotype of its antirecombination activity. Rad18 is
an E3 ubiquitin ligase that forms a functional complex
with Rad6, an E2 ubiquitin-conjugating enzyme. The Rad6-
Rad18 complex ubiquitylates PCNA; the ubiquitylated PCNA,
in turn, recruits translesion synthesis (TLS) polymerases to
bypass damaged nucleotides (Hoege et al. 2002; Bienko
et al. 2005). As expected, mutations affecting RAD18 or
RAD6 exhibit significant DNA damage sensitivity. srs2D
suppresses both rad6 and rad18 damage sensitivity by
allowing HR-mediated repair to be substituted for TLS-
mediated DNA damage tolerance. We hypothesized that if
srs2-F891A mutation affected the Srs2 antirecombination
activity, then srs2-F891A should also suppress rad18D MMS
sensitivity. Based on our findings, however, srs2-F891A does
not suppress rad18D DNA damage sensitivity, further sup-
porting the idea that this mutant is proficient at antirecombi-
nation (Figure 2C).
Figure 1 Mutations targeting the putative Srs2 BRC repeat-like motif weaken the Srs2–Rad51 physical interaction. (A) Schematic of Srs2 domains. (B)
Sequence alignment of the putative Srs2 BRC repeat motif with other BRC repeat motifs in the indicated species. Glycine (G): orange; phenylalanine (F),
isoleucine (I), leucine (L), alanine (A): blue; serine (S), threonine (T): green; proline (P): yellow; aspartic acid (D), glutamic acid (E): violet. (C) Quantitative
b-galactosidase assay analyzing the physical interaction between full-length Srs2 and Rad51. (D) Ni-NTA pull-down with 1.3 mM Rad51 and 0.4 mM
His9-tagged Srs2 (WT or srs2-F891A) at increasing concentrations of KCl (0–400 mM). Srs2 was visualized using a Biorad stain-free imaging system.
Rad51 bands were detected by immunoblot analysis. The amount of Rad51 pulled down was normalized against the amount of Srs2 pull-down in each
lane. Shown are means 61 SE, n = 2–3.
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In addition todamage sensitivity,we also investigated srs2-
F891A genetic interactions with sgs1D and rad54D, which
exhibit synthetic growth defect and synthetic lethality with
srs2D, genetic interactions linked to loss of Srs2 antirecombi-
nation function. These negative genetic interactions have
been attributed to the accumulation of toxic recombination
intermediates due to the absence of the Srs2 antirecombinase
activity (Palladino and Klein 1992; Gangloff et al. 2000).
Neither rad54D srs2-F891A nor sgs1D srs2-F891A double mu-
tants exhibit any synthetic lethality or growth defects (Figure
S5 in File S1).
srs2-F891A mutant is proficient at antirecombination
in vitro
The importance of Srs2–Rad51 interaction in Srs2 antire-
combination activity has primarily been demonstrated
in vitro and not in vivo. Several studies have shown that
blocking the Srs2–Rad51 interaction prevents Srs2 from
disrupting Rad51 filaments in vitro (Antony et al. 2009;
Colavito et al. 2009; Seong et al. 2009). We, therefore,
tested whether Srs2-F891A would exhibit a similar defect
in Rad51 filament disruption in vitro. We examined the
Rad51 filament disruption activity of Srs2-F891A in vitro
using magnetic beads coupled with ssDNA and bound by
Rad51 (Figure 3A) (Islam et al. 2012). Addition of either
Srs2 or Srs2-F891A was associated with a comparable in-
crease in the amount of Rad51 bound to scavenger DNA,
indicative of no defect in Rad51 filament disruption with
Srs2-F891A (Figure 3, B and C).
In summary, both our genetic and biochemical observa-
tions suggest srs2-F891A is proficient at antirecombination
both in vivo and in vitro despite the observed decrease in
its Rad51 interaction.
srs2-F891A exhibits a shift from NCO to CO repair
products in plasmid-based gap repair
The Srs2 antirecombinase activity has been shown to be
dependent on the Srs2–Rad51 physical interaction, partic-
ularly in vitro (Antony et al. 2009; Colavito et al. 2009;
Seong et al. 2009). However, other studies have also shown
Srs2 to play an important role in CO control (Aylon et al.
2003; Ira et al. 2003; Robert et al. 2006; Dupaigne et al.
2008; Mitchel et al. 2013; Miura et al. 2013). Interestingly,
more recently, the Srs2–Rad51 physical interaction has also
been implicated in regulating SDSA-mediated repair
(Miura et al. 2013). Removal of Srs2 amino acid residues
860 through 998, a deletion that is expected to disrupt the
Srs2–Rad51 interaction, results in a subtle but statistically
significant increase in SDSA repair efficiency in a plasmid-
based repair assay (Colavito et al. 2009; Miura et al. 2013).
Conversely, however, deletion of Srs2 amino acids 783–998
or 783–859, deletions also predicted to disrupt Rad51 in-
teraction, significantly decreases SDSA repair (Krejci et al.
2003; Miura et al. 2013). Despite the conflicting results
Figure 2 srs2-F891A mutation has no
effect on UV sensitivity, rad55D IR sen-
sitivity, or rad18D MMS sensitivity. (A)
Quantitative UV survival assay. The in-
dicated haploid W303 strains were
grown to stationary phase in liquid
YPD medium, plated onto YPD, UV ir-
radiated, and then grown at 30 for
2 days. The number of surviving colo-
nies was normalized to the number of
viable colonies in the unirradiated con-
trol samples. (B) Quantitative IR survival
assay. The indicated haploid W303
strains were grown to midlog phase,
irradiated with IR (0–200 Gy), and then
plated onto YPD and grown at 25 for
2 days. srs2-F891A, unlike srs2D, does
not suppress rad55D IR sensitivity. (C)
Qualitative MMS survival assay. Strains
were grown to stationary phase in liq-
uid YPD. Serial fivefold dilutions of the
strains were then spotted onto YPD
or 0.0006% MMS and grown at 30
for 1 day. The srs2D rad18D double
mutant appears white because it is
ADE21 unlike the other strains
depicted. srs2D suppresses rad18D
MMS sensitivity as expected. (D) Immu-
noblot analysis of whole cell protein
TCA extraction of WT and srs2-F891A
strains (W303 background). srs2D was
used as a negative control. Shown are
means 61 SE, n = 3.
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with the different Srs2 internal deletions, these findings
suggested that the Srs2–Rad51 interaction region also
plays a role in SDSA regulation. Given the reduced Rad51
interaction observed with Srs2-F891A, we were particu-
larly interested in examining how srs2-F891A mutation
might affect the Srs2 pro-SDSA function.
To assess SDSA in srs2-F891A, a previously developed
plasmid-based gap repair assay was employed to determine
whether srs2-F891A affects repair efficiency and CO to NCO
ratios in a manner similar to srs2D (Figure 4A) (Mitchel
et al. 2010, 2013). The gap repair assay relies on the trans-
formation of a linearized URA3 ARS plasmid missing 8 bp
from the middle of the 800-bp HIS3 marker. A chromoso-
mally integrated his3 mutant allele with the last 11 codons
missing is used as a repair template for the linearized plas-
mid. If the plasmid is repaired without associated CO
events, then the plasmid is not integrated and thus, in the
absence of selection, the URA3 marker will persist only
temporarily. However, if the plasmid repair is associated
with a CO event, then the plasmid will be chromosomally
integrated, thus leading to stable maintenance of the URA3
marker. This gap repair system examines the frequency of
His+ transformants, indicative of overall repair efficiency
and CO to NCO ratios, by measuring the fraction of His+
transformants that possess a stable URA3 marker. srs2D
showed a reduction in overall repair efficiency as previ-
ously reported (Mitchel et al. 2013), but srs2-F891A mu-
tants did not exhibit a significant change in overall gap
repair efficiency (Figure 4, B and C). The srs2-F891A mu-
tant did, however, display a statistically significant shift
from NCO to CO repair products in two different strain
backgrounds (W303 and SJR; Figure 4, B and C). It is im-
portant to note that the increase in CO frequency is not the
result of lower Srs2-F891A protein levels (Figure 2D). The
CO to NCO ratios observed in the srs2-F891A mutant
closely resemble the ratios observed in srs2D, even though
srs2-F891A, unlike srs2D, exhibits no measurable defect in
overall repair efficiency. This observation suggests the srs2-
F891Amutation specifically disables Srs2 pro-SDSA activity
while leaving its antirecombination activity intact. This ap-
parent separation-of-function mutation suggests that the
Srs2 pro-SDSA function may be independent of its well-
documented Rad51 filament disruption activity. This find-
ing also suggests that the Srs2-F891 residue mediating
Rad51 interaction may play a role in the Srs2 pro-SDSA
function.
Yeast Mph1 helicase, an ortholog of the human FANCM,
has been shown to promote an NCO outcome, likely
through its D-loop disruption activity observed in vitro
(Prakash et al. 2009). We reasoned that if Srs2 and Mph1
have partially overlapping functions, then mph1D srs2-
F891A double mutants might exhibit a greater shift toward
CO repair products than the single mutants. To test this, we
examined the genetic interaction betweenmph1D and srs2-
F891A in the gap repair system. srs2D mph1D double mu-
tants were excluded from the genetic analyses, because of
their severe synthetic growth defects and poor spore viabil-
ity (Tong et al. 2004; Chen et al. 2009; Prakash et al. 2009;
Panico et al. 2010). Similarly to srs2-F891A, earlier studies
showed that an mph1D mutant exhibits no gap repair de-
ficiency despite a clear shift from NCO to CO repair prod-
ucts (Mitchel et al. 2013). Our direct comparison of the two
mutants in the W303 background confirms this observation
(Figure 4B). Contrary to our expectation, the srs2-F891A
mph1D double mutants exhibited no increased shift toward
CO repair products beyond that observed in either single
mutant (Figure 4B). However, the double mutants did have
a synergistic defect in overall gap repair efficiency indica-
tive of a genetic interaction between srs2-F891A and
mph1D (Figure 4B). srs2-F891A and mph1D did not exhibit
any synergistic survival defects in response to IR, UV, or
MMS (Figure S4 in File S1). It is important to note that
the gap repair assay used here is limited to analyzing repair
products among the surviving cells. Therefore, it is possible
that CO events may be disproportionately represented
among dying cells, which may explain why the srs2-
F891A mph1D double mutants do not show the expected
synergistic increase in CO frequency. Altogether, our find-
ings suggest that while Srs2–Rad51 physical interaction as
Figure 3 Srs2-F891A and Srs2 disrupt Rad51 filaments at similar rates. In
vitro disruption of Rad51 filaments. (A) A schematic of the assay where
Rad51 filaments were assembled on ssDNA immobilized to magnetic
beads and disrupted by Srs2 or Srs2-F891A. (B) Supernatant Rad51 bound
to scavenger DNA with 25 nM of Srs2 or Srs2-F891A was analyzed by
immunoblot. A representative blot is shown. (C) Quantification of super-
natant Rad51 was normalized to fold increase over no Srs2 added. Shown
are means 61 SD, n = 3. The difference is not significant by a Student’s
t-test.
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mediated by Srs2-F891 residue is not critical for the Srs2
antirecombination function, it may play an important role
in SDSA/CO regulation in plasmid-based gap repair.
srs2-F891A exhibits wild-type NCO to CO ratios in an
ectopic physical assay
To confirm the plasmid-based gap repair findings and to
better evaluate the state of repair among the nonsurviving
cell populations, we used a previously designed ectopic
physical recombination assay with 1.9-kb homology of
1.4 and 0.5 kb flanking the DSB (Figure 5A) (Ira et al.
2003). We reproduced earlier findings showing an in-
crease in CO frequency in srs2D and mph1D mutants (Ira
et al. 2003; Xue et al. 2016). Surprisingly, this chromo-
some-based physical assay did not detect a measurable in-
crease in CO frequency in the srs2-F891Amutant (Figure 5,
B and C). Even the srs2-F891A mph1D double mutant did
not exhibit any further increase in CO frequency compared
to that observed in the mph1D single mutant (Figure 5, B
and C). In conclusion, even though the srs2-F891Amutants
in both W303 and SJR yeast strain backgrounds showed a
clear and reproducible shift from NCO to CO repair prod-
ucts in the plasmid-based gap repair assay, the ectopic
physical recombination assay did not detect a similar
effect.
srs2-F891A is proficient at spontaneous inverted
repeat recombination
Since the physical recombination assay, unlike the plasmid-
based gap repair assay, did not produce a phenotype for srs2-
F891A, we hypothesized the different outcomes in the two
assays may be linked to the variable extents of sequence
homology. Therefore, we tested the effects of the srs2-
F891A mutation in a previously designed intron-based spon-
taneous inverted repeat assay that provides limited sequence
homology (783 bp) and has previously detected a robust in-
crease in recombination rate in srs2D mutants (Figure 6A)
(Spell and Jinks-Robertson 2003, 2004b). We compared the
recombination rates of WT, srs2D, and srs2-F891A in the
inverted repeat assay. We detected a robust, eightfold in-
crease in srs2D recombination rates as previously reported;
however, the srs2-F891A mutation did not significantly in-
crease recombination rates (Figure 6B). This result confirms
the retention of antirecombination activity in the srs2-F891A
mutant but does not provide insight into the differences be-
tween the gap repair and physical assays.
Figure 4 srs2-F891A (W303 strain
background) increases the relative CO
frequency without affecting overall re-
pair efficiency. (A) Schematic of the
gap repair system. Plasmid linearized
within the HIS3 reading frame was
transformed into yeast strain where
his3D39 serves as the repair template
for the linearized plasmid. The stable
presence of the URA3 marker was used
as an indicator of plasmid integration,
representing CO events, while the un-
stable presence of the URA3 marker
was used an indicator of plasmid repair
without integration, representing NCO
events. (B) Gap repair assay shows that
srs2-F891A (W303 strain background)
has no defect in repair efficiency but
exhibits a clear shift from NCO repair prod-
ucts to CO repair products similar to
srs2D. All strains were MMR-defective
(mlh1D). Asterisks indicate a significant
difference when compared to WT using
a Student’s t-test (P # 0.05). (C) Gap
repair analysis of srs2-F891A in SJR
strain background recapitulates findings
in the W303 strain background.
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Srs2-F891A is proficient at dissolving stable
Rad51-catalyzed D-loops in vitro
Given that srs2-F891A exhibited a robust shift toward CO
repair products in the plasmid-based gap repair assay while
maintaining intact antirecombination activities, we hypothe-
sized that srs2-F891A may be specifically disabled in D-loop
disruption, an activity which has only recently been observed
in vitro (Liu et al. 2011). To address this possibility, we recon-
stituted Rad51-catalyzed D-loops in vitro and challenged
them with increasing concentrations of both WT and Srs2-
F891A mutant protein (Figure 7A). Surprisingly, despite the
robust shift in favor of CO repair in the plasmid-based repair
assay, the Srs2-F891A mutant protein showed no significant
defect in D-loop disruption in vitro (Figure 7, B and C).
Discussion
Srs2-mediated Rad51 filament disruption/antirecombina-
tion has long been proposed to require a physical interaction
with Rad51. This notion is largely supported by extensive
biochemical studies which have shown that Rad51 interac-
tion-deficient srs2mutants (C-terminal or internal deletions)
are also deficient in Rad51 filament disruption in vitro. How-
ever, genetic analyses of such Rad51 interaction-deficient
srs2 mutants are limited. Studies that have genetically and
cytologically examined Rad51 interaction-deficient srs2 mu-
tants with small internal deletions have found little evidence
for antirecombination defects in vivo (Colavito et al. 2009;
Burkovics et al. 2013; Sasanuma et al. 2013). By contrast,
C-terminal deletions of Srs2 that remove the Rad51 interac-
tion domain do exhibit antirecombination defects in genetic
analyses. These defects, however, are likely because of the
simultaneous deletion of the Srs2 PIP-like motif (PCNA-
interacting protein box spanning residues 1148–1161) as
well as the Srs2 SIM (Sumo interaction motif spanning resi-
dues 1168–1174) (Colavito et al. 2009; Armstrong et al.
2012). To further examine the biological significance of the
Figure 5 Ectopic physical recombination assay. (A) Schematic of the ec-
topic physical recombination assay. (B) Representative Southern blot anal-
ysis of the CO and NCO repair products for the strains shown in the
figure. (C) Quantitative analysis of the CO to NCO ratio. The lower CO
band intensities were divided by the sum of the lower CO and NCO
bands. In contrast to the gap repair system, the ectopic physical recom-
bination assay does not exhibit a shift from NCO to CO repair products
even in an mph1D background. Shown are means 61 SE, n = 3.
Figure 6 Spontaneous inverted repeat assay. (A) Schematic of the intron-
based inverted repeat recombination assay. Inverted repeats of cb2 intron
sequence (blue) are fused to intron splice sites (gray) positioned adjacent
to the 59 and 39 halves of the HIS3 gene (yellow). Spontaneous CO events
at cb2 intron sequence reorient and bring together the his3 halves. The
resulting transcript produces a functional HIS3 mRNA after splicing out
the cb2 intervening sequence. (B) Recombination rates for wild type and
srs2D recapitulate findings previously published (Spell and Jinks-Robertson
2003, 2004b). srs2-F891A mutant exhibits rates of recombination com-
parable to that of the wild type.
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Srs2–Rad51 physical interaction, we identified and con-
structed a single point mutation in the Srs2 C-terminal
Rad51 interaction region (srs2-F891A) that measurably re-
duces Rad51 binding in vivo and in vitro. Importantly, the
srs2-F891A mutation, unlike the C-terminal and internal
srs2 deletion mutations examined previously, appears to re-
tain the overall integrity of the protein with minimal effects
on other potential Srs2 functions, therefore reducing the like-
lihood of introducing confounding variables.
Based on our findings, Srs2-F891A, despite its weakened
interaction with Rad51, does not exhibit defects in antire-
combination in genetic analyses or when using in vitro assays.
Our in vivo findings are consistent with the previous genetic
analyses of Rad51 interaction-deficient srs2 mutants
(Colavito et al. 2009; Burkovics et al. 2013; Sasanuma et al.
2013). However, our in vitro findings are more surprising and
are discussed below.
Other groups have examined the role of the Srs2–Rad51
interaction domain with respect to antirecombination in vivo.
One study previously showed that deletion of a small region
in Srs2 (residues 875–902) effectively blocks interactions
with Rad51 (Colavito et al. 2009). It further showed that
purified Srs2-D(875–902) is unable to disrupt Rad51 fila-
ments. However, even though their biochemical findings
clearly showed a strong decrease in the Rad51 filament
disruption activity of this Srs2 mutant, the authors found
srs2-D(875–902) does not suppress the rad18D MMS or UV
sensitivity (Colavito et al. 2009; Burkovics et al. 2013). The
suppression of the rad18D DNA damage sensitivity by srs2D
has been attributed to loss of the Srs2 antirecombination
function such that Rad51-mediated repair can take the place
of the Rad18-mediated postreplicative repair (Lawrence and
Christensen 1979; Aguilera and Klein 1988; Aboussekhra
et al. 1989; Schiestl et al. 1994). To explain this inconsistency,
the authors hypothesized that srs2-D(875–902) failed to sup-
press rad18D DNA damage sensitivity because Srs2-D(875–
902) mutant protein may still maintain residual interaction
with Rad51. Another group also investigated the srs2-D(875–
902) mutant in their cytological analyses and found that
overexpression of Srs2-D(875–902) duringmeiosis still effec-
tively removed Rad51 foci in vivo (Sasanuma et al. 2013).
The results reported here also suggest that the Srs2–Rad51
interaction as mediated through Srs2 residue F891 may be
dispensable for Srs2-mediated antirecombination in vivo. The
apparent discrepancy between the in vivo and in vitro roles of
the Srs2–Rad51 interaction may be because in vivo there are
other factors, such as PCNA, that are equally, if not more,
important for the recruitment of Srs2 for Rad51 filament
disruption. In fact, a recent genetic study on SRS2 concluded
that the main role of Srs2 in DNA repair depends on its heli-
case/translocase activity instead of its Rad51or PCNA inter-
action (Bronstein et al. 2018).
While in vivo evidence supporting the biological signifi-
cance of Srs2–Rad51 interaction in antirecombination is lack-
ing, there is extensive biochemical evidence that shows this
interaction is required for Rad51 filament disruption in vitro
(Antony et al. 2009; Colavito et al. 2009). Therefore, the
robust Rad51 filament disruption activity of srs2-F891A
in vitro was surprising. Several studies have examined vari-
ous C-terminal deletions or small internal deletions of Srs2
that abrogate its interaction with Rad51 and have found
these mutant Srs2 proteins to be defective in Rad51 filament
disruption in vitro (Antony et al. 2009; Colavito et al. 2009;
Seong et al. 2009). This contrasts with our findings for
Figure 7 Both Srs2-F891A and Srs2 dissolve the D-loop in vitro. (A) Schematic of the reconstituted D-loop disruption assay. (B) Representative gel of
Srs2 and Srs2-F891A titration in D-loop disruption assay. (C) Quantification of D-loops in the presence of increasing concentrations of Srs2 and Srs2-
F891A proteins. Shown are means 61 SD, n = 3.
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Srs2-F891A. However, in contrast to the Srs2-F891A point
mutant, these mutants involve deletions of at least 27 residues,
which are expected to have more extensive effects on Srs2
function. Therefore, it is possible that the previous Rad51 in-
teraction-deficient srs2 mutants, given their larger deletion
sizes, have more wide-ranging effects on Srs2 activity.
Only one other study has explored an srs2 single mutation
(L844A) that measurably interferes with Srs2–Rad51 inter-
action; however, Srs2-L844A, unlike Srs2-F891A, was shown
to exhibit reduced Rad51 filament disruption compared to
WT Srs2, as extrapolated from D-loop assays (Islam et al.
2012). Others have previously proposed that the Srs2–
Rad51 interaction is likely mediated by Srs2 residues clus-
tered in separate regions within Srs2 residues 783–998
(Keyamura et al. 2016). It is also possible that these separate
Rad51 interaction regions affect different aspects of Srs2
function, with the region around L844 mediating Srs2 anti-
recombination and the region around F891 mediating Srs2
pro-SDSA function.
As discussed earlier, the Srs2–Rad51 interaction has been
implicated in SDSA regulation (Miura et al. 2013). In studies
by Miura et al. SDSA repair efficiency was assayed in a gap
repair assay that requires the invasion of two distinct ectopic
donor alleles, thus limiting repair to SDSA (Miura et al.
2013). Interestingly, the authors showed that srs2-D(860–
998) results in an increase in the overall efficiency of gap
repair, interpreted as an increase in SDSA-mediated repair
(Miura et al. 2013). This may appear in conflict with our
findings which show that srs2-F891A mutation, which falls
within the same deleted region, decreases SDSA-mediated
repair. However, given the size of the deletion in the earlier
study, one cannot assume that srs2-D(860–998) disables only
the Srs2–Rad51 interaction without affecting other func-
tions. In fact, this deletion mutation may have also removed
a region that is responsible for negatively regulating the pro-
SDSA functions of Srs2, leading to the reported increase in
SDSA-mediated repair. Furthermore, the work reported here
and that presented in Miura et al. (2013) utilize significantly
different plasmid repair assays. While the Miura et al. (2013)
assay limits repair events exclusively to SDSA, the plasmid-
based assay used here allows either NCO or CO pathways.
The significant differences in these assays may be the under-
lying cause for the observed SDSA effects.
Lastly, while srs2-F891A exhibited a clear shift from NCO
to CO repair products in the plasmid-based gap repair system,
this shift is not observed in the ectopic physical recombina-
tion assay. A fundamental difference between the two assays
is the extent to which the broken DNA substrates may be
resected. In fact, a previous publication has shown that, un-
like chromosome-based recombination assays, loss of DNA
resection enzymes actually improves overall repair efficiency
in the plasmid-based gap repair system (Guo and Jinks-Rob-
ertson 2013). This is largely attributed to destruction of
linearized plasmids by Exo1- or Sgs1-Dna2-mediated long-
range resection before repair can take place. We can thus
infer that the transformants isolated from such plasmid-based
gap repair assays correspond to a minority of repair events that
have escaped extensive resection. Assuming this, the resulting
D-loops may vary with respect to their size and overall stability.
If Srs2 does, in fact, promote SDSA by dissolving extended
D-loops, then the presumably longer and more stable D-loops
in chromosome-based recombination assays may be refractory
to Srs2-mediated dissolution.
Another difference between both crossover systems is
homology length. The plasmid-based crossover system has
400-bp homologies flanking the DSB (Mitchel et al. 2010,
2013); in the chromosomal system 1400-bp and 500-bp
homologies flank the DSB (Ira et al. 2003). It is possible that
the shorter homology results in different types or sizes of
D-loops that are more dependent on processing by Srs2. Un-
fortunately, physical chromosomal systems with homology
lengths similar to the plasmid-based system do not result in
measurable crossover frequencies (Inbar et al. 2000), making
it difficult to test the homology length parameter.
Alternatively, as it has been proposed by Prado and Agui-
lera (2003), extensively resected DNA substrates with limited
homology to the donor sequence are likely channeled into the
SDSA subpathway, producing exclusively NCO repair prod-
ucts (Prado and Aguilera 2003). Therefore, extensive resec-
tion of chromosomal substrates, such as the chromosomal
substrates in the ectopic physical assay used here, likely com-
mits the intermediates to the SDSA subpathway. The exten-
sively resected chromosomes can persist until repaired
through SDSA, consequently minimizing the effect Srs2
may have on the CO to NCO ratios. In contrast, the broken
ends in the plasmid-based gap repair system may have a very
short and transient window to successfully repair the gap,
beyond which they become degraded and unrepairable.
The minimally resected broken ends maintain the capacity
to go through the dHJ pathway with the potential to still
generate CO repair products as well as NCOs. Therefore,
Srs2 activity on such substrates can still measurably sway
the relative frequency of repair products.
In summary, we have identified a novel srs2mutation that,
at least in part, behaves as a separation-of-function mutation
that specifically inactivates the Srs2 pro-SDSA function in the
plasmid-based gap repair system while maintaining its anti-
recombination function. Our findings reveal the complexity
of the Srs2–Rad51 interaction and suggest a possible role for
the Srs2–Rad51 interaction in SDSA/CO regulation.
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